欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0040/002
药品名称Hivid Roche 0.75 mg
活性成分
    • zalcitabine 750.0 µg
剂型Film-coated tablet
上市许可持有人Hoffmann-La Roche AG Emil-Barell-Str. 1 D-79639 Grenzach-Wyhlen
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
      Hivid Roche 0.75
    • Belgium (BE)
      Hivid Roche 0.375
    • Netherlands (NL)
      Hivid Roche 0.375
    • Luxembourg (LU)
      Hivid Roche 0.375
    • United Kingdom (Northern Ireland) (XI)
      Hivid Roche 0.375
    • Ireland (IE)
      Hivid Roche 0.375
    • Austria (AT)
      Hivid "Roche" 0,75 mg - Filmtabletten
    • France (FR)
      Hivid Roche 0.375
    • Spain (ES)
      Hivid Roche 0.375
    • Portugal (PT)
      Hivid Roche 0.375
    • Italy (IT)
      Hivid Roche 0.375
    • Greece (GR)
      Hivid Roche 0.375
    • Sweden (SE)
      Hivid Roche 0.75
    • Finland (FI)
      Hivid Roche 0.75
许可日期2008/04/05
最近更新日期2012/08/09
药物ATC编码
    • J ANTIINFECTIVES FOR SYSTEMIC USE
    • J05 ANTIVIRALS FOR SYSTEMIC USE
    • J05A DIRECT ACTING ANTIVIRALS
    • J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
    • J05AF03 zalcitabine
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase